Abstract:
Introduction: Clinical verifi cation is an ongoing research program of the Council that verifi ed many rare homoeopathic drugs. Aim: To clinically
verify the ‘symptomatology’ of Mangifera indica by ascertaining the symptoms improved during verifi cation. Materials and Methods: The
study was a multicentric open label observational trial. Total 114 patients were enrolled after matching with the available symptom compendium
and eligibility criteria in fi ve centres of the Council. The medicine was prescribed in 6C, 30C, 200C and 1M potencies, as per need of the
patient following the homoeopathic principles and protocol developed by the Council. The collected data were presented in terms of descriptive
statistics. Prevalence of symptoms in the responding and non-responding population has been compared using Chi-square test. Results: Among
the total 114 patients enrolled in the study, 77 patients who completed the follow up were analysed, as there were 37 drop out cases. The
demographic analysis shows, male/female: 41/36, mean age 28.61 years. There was “clinical success” in 65 cases (84.41%) and failures in
12 cases (15.59%), judged subjectively by the physicians. A minimum of two prescriptions were considered for pick listing each symptom as
a rule of thumb. Conclusions: Total 16 CCRH proving symptoms were verifi ed, 4 symptoms from other literatures were also verifi ed. 51 new
clinical symptoms/symptom components were identifi ed. Further replication and estimation of likelihood ratio in general practice setting is
crucial for confi rmation and inclusion of such symptoms in homoeopathic literatures.
